Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Status unconfirmed · Phase 3
Conditions studied: Amyotrophic Lateral Sclerosis (ALS)
In brief
The purpose of this study is to determine whether nine months of administration of creatine monohydrate results in an increase in muscle strength in patients with amyotrophic lateral sclerosis (ALS).
Key facts
- Study ID
- NCT00069186
- Run by
- The Avicena Group
- People needed
- 107
- Starts
- 2003-06-01
- Expected to finish
- 2005-04-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, San Francisco — San Francisco, California, United States
- University of Kansas — Kansas City, Kansas, United States
- University of New Mexico — Albuquerque, New Mexico, United States
- Carolinas Medical Center — Charlotte, North Carolina, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Oregon Health Sciences University — Portland, Oregon, United States
- University of Texas Health Science Center — San Antonio, Texas, United States
- University of Virginia Health System — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.